Abcam Investor Relations Material
Latest events
H2 2022
Abcam
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Abcam plc
Access all reports
Abcam plc is a global provider of life science research tools, specializing in the development and marketing of reagents and tools essential for research in the life sciences sector. The company's extensive product range includes primary and secondary antibodies, immunoassay kits, cellular and biochemical assays, proteins and peptides, as well as products for cell and tissue imaging. Abcam serves a broad array of customers including researchers in academia, clinical labs, and pharmaceutical, biotech, and diagnostic companies. Abcam is headquartered in Cambridge, Cambridgeshire, UK, and its shares are listed on the Nasdaq.
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
ABCM
Country
🇺🇸 United States